Skip to main content

Editorial Board

Michael Pollak, McGill University and Lady Davis Research Institute, Canada
Matthew Vander Heiden, Massachusetts Institute of Technology, USA

Editor Emeritus
Chi Van Dang, Abramson Cancer Centre, University of Pennsylvania, USA

Associate Editors:
Kivanc BirsoyThe Rockefeller University, USA
Kevin BrindleUniversity of Cambridge, UK
Navdeep ChandelNorthwestern University, USA
Teresa FanMarkey Cancer Center, USA
Lydia Finley, Memorial Sloan Kettering Cancer Center, USA 
Rudolf KaaksGerman Cancer Research Center, Germany
Richard G. KibbeyYale University School of Medicine, USA
Costas LyssiotisUniversity of Michigan, USA
Rachel PerryYale University School of Medicine, USA
Reuben ShawThe Salk Institute for Biological Studies, USA
Julie St-PierreUniversity of Ottawa, Canada
Alexei VazquezUniversity of Glasgow, UK
Kathryn Wellen, University of Pennsylvania, USA

Editorial Board Members:
Abass AlaviUniversity of Pennsylvania School of Medicine, USA
Lewis Cantley, Weill Cornell Medical College, USA
Peter CarmelietVesalius Research Center, Belgium
Gina DeNicola, Moffitt Cancer Center, USA
Robert Gatenby, Moffitt Cancer Center, USA
Kun-Liang GuanUniversity of  California, USA
Andrew LaneMarkey Cancer Center, USA
Sophia Lunt, Michigan State University, USA
Christian MetalloUniversity of California, San Diego Department of Bioengineering, USA
Gordon Mills, University of Texas M. D. Anderson Cancer Center, USA
Michael E PacoldNew York University Langone Health, USA
Thales Pappagiannokopoulos, NYU Grossman School of Medicine, USA
Jacques PouyssegurInstitute of Research on Cancer and Aging, France
Joshua Rabinowitz, Princeton University, USA
Peter RatcliffeNuffield Department of Clinical Medicine, UK
Jeffrey RathmellDuke University, USA
Jared RutterUniversity of Utah School of Medicine, USA
David Sabatini, Whitehead Institute for Biomedical Research, USA
Gregg Semenza, Johns Hopkins University School of Medicine, USA
Celeste Simon, University of Pennsylvania School of Medicine, USA
Bert Vogelstein, Johns Hopkins University School of Medicine, USA
Karen Vousden, Beatson Institute for Cancer Research, UK
Eileen White, The Cancer Institute of New Jersey, USA

Impact of COVID-19

COVID-19 © elipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.

Annual Journal Metrics

  • Speed
    79 days to first decision for reviewed manuscripts only
    51 days to first decision for all manuscripts
    200 days from submission to acceptance
    47 days from acceptance to publication

    Citation Impact

    5.033 - 2 Year Impact Factor
    0.583 - Immediacy Index

    553 Altmetric Mentions